Goldman Sachs’s Foundation Medicine, Inc. FMI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-170,797
| Closed | -$23.3M | – | 5974 |
|
|
2018
Q2 | $23.3M | Buy |
170,797
+107,685
| +171% | +$9.78M | 0.01% | 1764 |
|
|
2018
Q1 | $4.97M | Buy |
63,112
+24,916
| +65% | +$1.84M | ﹤0.01% | 2890 |
|
|
2017
Q4 | $2.6M | Buy |
38,196
+1,019
| +3% | +$52.8K | ﹤0.01% | 3566 |
|
|
2017
Q3 | $1.5M | Sell |
37,177
-3,088
| -8% | -$119K | ﹤0.01% | 4232 |
|
|
2017
Q2 | $1.6M | Sell |
40,265
-4,155
| -9% | -$152K | ﹤0.01% | 4015 |
|
|
2017
Q1 | $1.43M | Sell |
44,420
-5,935
| -12% | -$148K | ﹤0.01% | 4057 |
|
|
2016
Q4 | $891K | Buy |
50,355
+28,174
| +127% | +$607K | ﹤0.01% | 4557 |
|
|
2016
Q3 | $518K | Buy |
22,181
+796
| +4% | +$18.1K | ﹤0.01% | 5010 |
|
|
2016
Q2 | $399K | Buy |
21,385
+4,473
| +26% | +$80.8K | ﹤0.01% | 5072 |
|
|
2016
Q1 | $307K | Buy |
16,912
+1,820
| +12% | +$29.3K | ﹤0.01% | 5253 |
|
|
2015
Q4 | $318K | Buy |
+15,092
| New | +$291K | ﹤0.01% | 5306 |
|
|
2015
Q3 | – | Sell |
-82,018
| Closed | -$2.77M | – | 7618 |
|
|
2015
Q2 | $2.77M | Buy |
82,018
+27,862
| +51% | +$1.12M | ﹤0.01% | 3512 |
|
|
2015
Q1 | $2.6M | Buy |
54,156
+32,609
| +151% | +$1.48M | ﹤0.01% | 3521 |
|
|
2014
Q4 | $479K | Sell |
21,547
-35,840
| -62% | -$827K | ﹤0.01% | 5326 |
|
|
2014
Q3 | $1.09M | Sell |
57,387
-135,773
| -70% | -$3.24M | ﹤0.01% | 4519 |
|
|
2014
Q2 | $5.21M | Buy |
193,160
+33,395
| +21% | +$847K | ﹤0.01% | 2987 |
|
|
2014
Q1 | $5.17M | Buy |
159,765
+6,202
| +4% | +$202K | ﹤0.01% | 2983 |
|
|
2013
Q4 | $3.66M | Buy |
+153,563
| New | +$4.29M | ﹤0.01% | 3437 |
|
Goldman Sachs's FMI Position: Q3 2018 in Review
Goldman Sachs sold out of Foundation Medicine, Inc. (FMI) in Q3 2018, closing a stake of 170,797 shares — an estimated $23.3M sold.
Goldman Sachs first reported a position in FMI in Q4 2013 and held it in 18 quarters. The position peaked at $23.3M in Q2 2018. 0 funds tracked by Wall St. Rank hold FMI as of Q3 2018.
- Goldman Sachs reported no remaining Foundation Medicine, Inc. position as of Q3 2018 after selling out during the quarter.
- Goldman Sachs sold 170,797 Foundation Medicine, Inc. shares in Q3 2018, an estimated $23.3M.
- Goldman Sachs first reported a position in Foundation Medicine, Inc. in Q4 2013 and held it in 18 quarters.
- Goldman Sachs's Foundation Medicine, Inc. position peaked at $23.3M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2018.
Based on Goldman Sachs's 13F filing for Q3 2018, filed 14 Nov 2018.